Skip to content
Never before have humans been so readily connected. And while global connectivity is great for staying in touch with friends or family or working […]
Accumulus Synergy cloud platform shows ‘the art of the possible’ Read More »
Sharon King’s daughter Taylor was a happy surprise. And up until Taylor was in the first grade, she was developing normally. But the first
Bespoke Gene Therapy Consortium gives rare disease biotechs a path forward Read More »
March is Autoimmune Awareness Month, so Bio.News has partnered with The Autoimmune Association to talk about the top five things you need to know
Top 5 things to know during Autoimmune Disease Awareness Month Read More »
The Colorado Prescription Drug Affordability Board (PDAB) has many patients, patient advocacy groups, and bioscience organizations in the state worried. As one of the
Colorado PDAB could limit patient access to medicines Read More »
During the State of the Union address on March 7, President Biden said, “Women are more than half of our population, but research on
BIO’s Women’s Health Task Force fosters greater innovation in women’s health Read More »
As fashion weeks in both the U.S. and Europe come to a close, it begs the question of staying fashionable and environmentally friendly. In
Biotech fashion takes naturally sourced textiles literally Read More »
Mergers and acquisitions (M&A) are important elements of the biotech industry, especially for early-stage fundraising and bringing new drugs and treatments to the market.
What biotech companies should know about M&A in down markets Read More »
The metabolic field is the hottest biotech therapeutic area of the year (and likely to continue beyond). In the context of a difficult couple
The future of next-generation obesity drugs Read More »
The biotech industry must constantly navigate the ins and outs of Beltway politics. During an election year, the need to anticipate and plan for
What policy biotech should be watching this election year Read More »
The Biotechnology Innovations Organization (BIO) report, The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases, on January 25, 2024, found that
CEOs explore challenges and opportunities in vaccine pipeline Read More »
